Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

MAP-2021-1000x250-Single-Bubble

The MAP 2021 Virtual abstract submission system is now closed

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-August 2021.

Abstract submission deadlines

Deadline

Date and time

  • Abstracts
  • Trial in Progress

Wednesday, 28 July 2021
21:00 CEST (Central European Summer Time)

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the MAP 2021 Virtual Congress.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of Wednesday, 28 July 2021.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts will be accepted for Poster outcome only.
  • Encore TiP abstracts will NOT be accepted.

Abstracts will be reviewed by the MAP 2021 Virtual Scientific Committee and considered on the merits of the scientific and clinical rationale of the trial.

Publication schedule for accepted abstracts

Abstracts accepted for presentation during MAP 2021 Virtual (Proffered Paper/Mini Oral and Poster) and for publication in the MAP 2021 Virtual Abstract Book, will be published online on the MAP 2021 Virtual Website on Monday, 4 October 2021.

Abstracts

Date and time

Abstracts accepted as:

  • Mini Oral (suffix ‘MO’)
  • Poster (suffix ‘P’)
  • Trial in Progress (suffix ‘TiP’)

Monday, 4 October
12:00 Central European Summer Time (CEST)

Embargo policy

Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.

Data and information beyond what is included in all accepted abstracts, for example full data sets, may only be made public at the start of the official programme session during which the study is presented.

Presentation options for accepted abstracts

Presenters may request an outcome based on the following options. The MAP 2021 Virtual Scientific Committee reserves the right to decide which of these session formats will be scheduled during the Congress.

  • Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
  • e-Poster – e-Posters will be on display on the Congress platform for consultation.

All accepted abstracts will be published online in the MAP 2021 Virtual Abstract Book.

Detailed instructions for the preparation of visual presentations and posters will be made available on the MAP 2021 Virtual website along with scheduling notices from mid-August 2021.

All accepted abstracts will be published in the MAP 2021 Virtual Abstract Book, a supplement of the official ESMO journal Annals of Oncology.

More information can be found in the Abstract regulations.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings